Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?

ISTH Academy, Willem Lijfering, 219331

Safety and effectiveness of apixaban compared to warfarin in dialysis patients

ISTH Academy, Correspondence |Daniel Reed, 219332

MMP‐13 binds to platelet receptors αIIbβ3 and GPVI and impairs aggregation and thrombus formation

ISTH Academy, Joanna-Marie Howes, 219333

Effects of anti‐β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity

ISTH Academy, Jorge DiPaola, 219334

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction

ISTH Academy, Michael Nagler, 219346

“Trending” statistical methods

ISTH Academy, George Howard, 219347

Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative

ISTH Academy, Mary Cushman, 219348

Blood Flow Regulation of Platelet Function and Coagulation

ISTH Academy, Keith Neeves & Pierre Mangin, 210956

Module 7: Treatment of Venous Thrombosis

ISTH Academy, Clive Kearon, 212539

Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study

ISTH Academy, Willem Lijfering, 219425

The influence of thyroid function on the coagulation system and its clinical consequences

ISTH Academy, Laura P. B. Elbers, 219426

Issue Information

ISTH Academy, Session Speakers, 219427

Polymorphism in dural arteriovenous fistula: matrix metalloproteinase‐2‐1306 C/T as a potential risk factor for sinus thrombosis

ISTH Academy, Chao‐Bao Luo, 219428

The role of ADAMTS‐13 in the coagulopathy of sepsis

ISTH Academy, Marcel Levi, 219429

Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect

ISTH Academy, Rolf Urbanus, 219430

Predictors and causes

ISTH Academy, Session Speakers, 219431

Thrombin‐reduced miR‐27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti‐angiogenic thrombospondin‐1

ISTH Academy, Nailin Li, 219432

Viral safety of coagulation factor concentrates: memoirs from an insider

ISTH Academy, Pier Mannuccio Mannucci, 219433

Platelets couple inflammation to tumorigenesis, a bridge too far

ISTH Academy, Joseph Palumbo, 219434

Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey

ISTH Academy, Marianne A. Grant, 219435

Aspirin withdrawal in patients treated with ticagrelor presenting with non‐ST elevation myocardial infarction

ISTH Academy, Roy Beigel, 219436

Measuring fibrinolysis: from research to routine diagnostic assays

ISTH Academy, Colin Longstaff, 219437

Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study

ISTH Academy, Pamela L. Lutsey, 219438

Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

ISTH Academy, Johanna Kremer Hovinga, 219439

Coagulation and inflammation in long‐term cancer survivors: results from the adult population

ISTH Academy, Marina Panova-Noeva, 219440

Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non‐cardiac surgery: an observational cohort study

ISTH Academy, Thomas Thiele, 219441

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 219442

Magnetic fibrinolysis: putting the therapeutic wheels in a corkscrew motion

ISTH Academy, Robert Medcalf, 219443

The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department

ISTH Academy, Frederikus Klok, 219444

Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement

ISTH Academy, Flora Peyvandi, 219445

Platelets contribute to the initiation of colitis‐associated cancer by promoting immunosuppression

ISTH Academy, Cecile Oury, 219446

Androgen receptor dampens tissue factor expression via nuclear factor‐κB and early growth response protein 1

ISTH Academy, Bastian Hoesel, 219447

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

ISTH Academy, Katrien Devreese, 219448

What the neighbors say

ISTH Academy, Session Speakers, 219449

The effect of recanalization on long‐term neurological outcome after cerebral venous thrombosis

ISTH Academy, Francesco Dentali, 219450

Non-factor therapies in hemophilia

ISTH Academy, Steven Pipe & Guy Young, 210955

French lyophilized plasma versus fresh frozen plasma for the initial management of trauma‐induced coagulopathy: a randomized open‐label trial

ISTH Academy, Sophie Susen, 212241

Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta‐analyses revisited

ISTH Academy, Christian J. Wiedermann, 212242

International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories

ISTH Academy, Kenneth Friedman, 212243

Scope

ISTH Academy, Session Speakers, 212244

Issue Information

ISTH Academy, Session Speakers, 212245

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

ISTH Academy, Vittorio Pengo, 212246

High and long‐term von Willebrand factor expression after Sleeping Beauty transposon‐mediated gene therapy in a mouse model of severe von Willebrand disease

ISTH Academy, Simon F. De Meyer, 212247

Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis

ISTH Academy, Jeffrey I. Weitz, 212248

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor: reply

ISTH Academy, Andrew Frelinger, 212249

Staphylococcus aureus, master manipulator of the human hemostatic system

ISTH Academy, Thomas Vanassche, 212250

The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo

ISTH Academy, Sriram Neelamegham, 212251

von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice

ISTH Academy, Sandra Haberichter, 212252

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 212253

Antithrombin concentrate use in sepsis‐associated disseminated intravascular coagulation: re‐evaluation of a ‘pendulum effect’ drug using a nationwide database

ISTH Academy, Takashi Tagami, 212254

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme

ISTH Academy, Armando Tripodi, 212255

Erratum

ISTH Academy, Session Speakers, 212256

Dabigatran versus vitamin k antagonist: an observational across‐cohort comparison in acute coronary syndrome patients with atrial fibrillation

ISTH Academy, Laurence Camoin‐Jau, 212257

Multiplate evaluation of acetylsalicylic acid efficacy in carotid surgery: routine and genetic influencing factors

ISTH Academy, Stéphanie Roullet, 212258

Oxidized low‐density lipoprotein in inflammation‐driven thrombosis

ISTH Academy, Christoph Binder, 212259

Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population

ISTH Academy, Willem Lijfering, 212260

Optimal patient selection for anticoagulant therapy in sepsis: an evidence‐based proposal from Japan

ISTH Academy, Kazuma Yamakawa, 212261

Musculoskeletal ultrasound for intra‐articular bleed detection: a highly sensitive imaging modality compared with conventional magnetic resonance imaging

ISTH Academy, Annette von Drygalski, 212262

Early cellular interactions and immune transcriptome profiles in human factor VIII‐exposed hemophilia A mice

ISTH Academy, David Lillicrap, 212263

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor: comment

ISTH Academy, Mohammad Urooj Zafar, 212264

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients

ISTH Academy, Ingrid Pabinger-Fasching, 212265

Metabolomic analysis of 92 pulmonary embolism patients from a nested case–control study identifies metabolites associated with adverse clinical outcomes

ISTH Academy, Christopher Kabrhel, 212266

Acquired coagulopathy in patients with left ventricular assist devices

ISTH Academy, Frank Leebeek, 212267

What the neighbors say

ISTH Academy, Session Speakers, 212268

The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study

ISTH Academy, Krishnarajah Nirantharakumar, 212269

Perioperative management of patients receiving anticoagulants and antiplatelet drugs

ISTH Academy, Alex C. Spyropoulos & Geoff Barnes, 214366

Issue Information

ISTH Academy, Session Speakers, 212215

Hemodynamic force triggers rapid NETosis within sterile thrombotic occlusions

ISTH Academy, Scott Diamond, 212216

Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency

ISTH Academy, Flora Peyvandi, 212217

Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm

ISTH Academy, Nicoletta Riva, 212218

An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura

ISTH Academy, Karen Vanhoorelbeke, 212219

Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis

ISTH Academy, Anat Rabinovich, 212220

At the MERcy of platelet primers

ISTH Academy, Judith Cosemans, 212221

Expression and functional characterization of two natural heparin‐binding site variants of antithrombin

ISTH Academy, Alireza R. Rezaie, 212222

What the neighbors say

ISTH Academy, Session Speakers, 212223

Platelet collagen receptor Glycoprotein VI‐dimer recognizes fibrinogen and fibrin through their D‐domains, contributing to platelet adhesion and activation during thrombus formation

ISTH Academy, Stephanie Jung, 212224

Open, open, open

ISTH Academy, Session Speakers, 212225

Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues

ISTH Academy, Christoph Male, 212226

Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation

ISTH Academy, John Lollar, 212227

Comorbidity and the increased mortality after hospitalization for stroke: a population‐based cohort study

ISTH Academy, Priscila Corraini, 212228

Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood–brain barrier dysfunction

ISTH Academy, Dirk Hendriks, 212229

A humanized monoclonal antibody that inhibits platelet‐surface ERp72 reveals a role for ERp72 in thrombosis

ISTH Academy, Lisa‐Marie Holbrook, 212230

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 212231

Greetings from the endoplasmic reticulum (ER): escaping ER thiol isomerases regulate thrombosis

ISTH Academy, Beate Kehrel, 212232

High‐molecular‐weight kininogen: breaking bad in lethal endotoxemia

ISTH Academy, Coen Maas, 212233

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

ISTH Academy, Jonathan Douxfils, 212234

Negative regulators of platelet activation and adhesion

ISTH Academy, Lucia Stefanini, 212235

Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis

ISTH Academy, Toshiaki Iba, 212236

Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta‐analysis

ISTH Academy, Christine Kohn, 212237

The small‐molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis

ISTH Academy, Jorge DiPaola, 212238

Recommendations for future research in relation to pediatric pulmonary embolism: communication from the SSC of the ISTH

ISTH Academy, Tina Biss, 212239

Genes associated with venous thromboembolism in colorectal cancer patients

ISTH Academy, Henri Versteeg, 212240

ISTH 2017 Berlin revisited

ISTH Academy, Correspondence |Wolfram Ruf, 205271

What you don't know can kill you

ISTH Academy, Geoffrey Barnes, 205272

Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S

ISTH Academy, Alan Mast, 205273

Global public awareness about atrial fibrillation

ISTH Academy, Aaron Wendelboe, 205284

Current issues in diagnosis and treatment of von Willebrand disease

ISTH Academy, Veronica Flood, 205285

N‐methyl‐d‐aspartate receptor mediated calcium influx supports in vitro differentiation of normal mouse megakaryocytes but proliferation of leukemic cell lines

ISTH Academy, Maggie Kalev-Zylinska, 205286

Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk

ISTH Academy, Christopher Austin, 205287

Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism

ISTH Academy, Manuela Albisetti Pedroni, 205288